BioCentury
ARTICLE | Financial News

Go gets $5M from Salubris

September 29, 2017 9:34 PM UTC

On Sept. 25, the Salubris Pharmaceutical Ltd. subsidiary of Shenzhen Salubris Pharmaceuticals Co. Ltd. (SZSE:002294) invested $5 million in cancer company Go Therapeutics Inc. (Cambridge, Mass.)....